Variant report

Variant	esv3408932
Chromosome Location	chr5:94619021-94621569
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:359)
CpG islands
(count:551)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:359 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr5:94620929-94621103	H1-hESC	embryonic stem cell:	n/a	n/a
2	CCNT2	chr5:94619815-94620025	K562	blood:	n/a	n/a
3	CHD1	chr5:94620443-94621239	H1-hESC	embryonic stem cell:	n/a	n/a
4	CHD2	chr5:94619666-94619789	Hela-S3	cervix:	n/a	n/a
5	CHD2	chr5:94619743-94620012	H1-hESC	embryonic stem cell:	n/a	n/a
6	CHD2	chr5:94620181-94620425	Hela-S3	cervix:	n/a	n/a
7	CREB1	chr5:94619683-94619942	A549	lung:	n/a	n/a
8	CTBP2	chr5:94619497-94621226	H1-hESC	embryonic stem cell:	n/a	n/a
9	CTCF	chr5:94620916-94621149	LNCaP	prostate:	n/a	n/a
10	CTCF	chr5:94619760-94619910	HCFaa	heart:	n/a	n/a
11	CTCF	chr5:94619658-94620211	MCF-7	breast:	n/a	n/a
12	CTCF	chr5:94619560-94619710	A549	lung:	n/a	n/a
13	CTCF	chr5:94620020-94620170	HA-sp	spinal cord:	n/a	n/a
14	CTCF	chr5:94619668-94620142	MCF-7	breast:	n/a	n/a
15	CTCF	chr5:94619760-94619910	GM12878	blood:	n/a	n/a
16	CTCF	chr5:94619585-94620136	MCF-7	breast:	n/a	n/a
17	CTCF	chr5:94619672-94619948	GM10248	blood:	n/a	n/a
18	CTCF	chr5:94619760-94619910	GM12872	blood:	n/a	n/a
19	CTCF	chr5:94620065-94620146	LNCaP	prostate:	n/a	n/a
20	CTCF	chr5:94619760-94619910	GM12874	blood:	n/a	n/a
21	CTCF	chr5:94619691-94619913	K562	blood:	n/a	n/a
22	CTCF	chr5:94620880-94621030	GM12871	blood:	n/a	n/a
23	CTCF	chr5:94619682-94619963	GM19240	blood:	n/a	n/a
24	CTCF	chr5:94619680-94620169	GM12891	blood:	n/a	n/a
25	CTCF	chr5:94619712-94619926	H1-hESC	embryonic stem cell:	n/a	n/a
26	CTCF	chr5:94619681-94619953	Fibrobl	skin:	n/a	n/a
27	CTCF	chr5:94620680-94620713	MCF-7	breast:	n/a	n/a
28	CTCF	chr5:94619760-94619910	HA-sp	spinal cord:	n/a	n/a
29	CTCF	chr5:94619720-94619870	AoAF	blood vessel:	n/a	n/a
30	CTCF	chr5:94619780-94619930	HMF	breast:	n/a	n/a
31	CTCF	chr5:94620997-94621067	K562	blood:	n/a	n/a
32	CTCF	chr5:94619720-94619870	Hela-S3	cervix:	n/a	n/a
33	CTCF	chr5:94619780-94619930	HRPEpiC	eye:	n/a	n/a
34	CTCF	chr5:94619690-94619989	IMR90	lung:	n/a	n/a
35	CTCF	chr5:94619740-94619890	HBMEC	blood vessel:	n/a	n/a
36	CTCF	chr5:94620900-94621050	SK-N-SH_RA	brain:	n/a	n/a
37	CTCF	chr5:94620964-94621126	GM19238	blood:	n/a	n/a
38	CTCF	chr5:94619760-94619910	HBMEC	blood vessel:	n/a	n/a
39	CTCF	chr5:94619710-94619943	GM13977	blood:	n/a	n/a
40	CTCF	chr5:94619780-94619930	HCT-116	colon:	n/a	n/a
41	CTCF	chr5:94619740-94619890	AG04450	lung:	n/a	n/a
42	CTCF	chr5:94620940-94621090	GM12865	blood:	n/a	n/a
43	CTCF	chr5:94619740-94619890	AG04449	skin:	n/a	n/a
44	CTCF	chr5:94620898-94621141	MCF-7	breast:	n/a	n/a
45	CTCF	chr5:94619760-94619910	HAc	cerebellar:	n/a	n/a
46	CTCF	chr5:94621020-94621170	GM12873	blood:	n/a	n/a
47	CTCF	chr5:94619760-94619910	HEK293	kidney:	n/a	n/a
48	CTCF	chr5:94620000-94620150	HUVEC	blood vessel:	n/a	n/a
49	CTCF	chr5:94620070-94620124	GM12892	blood:	n/a	n/a
50	CTCF	chr5:94620960-94621110	WERI-Rb-1	eye:	n/a	n/a

(count:551 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:94620134-94620184	HEEpiC	esophagus:	n/a
2	chr5:94620042-94620092	Hepatocyte	liver:	n/a
3	chr5:94620134-94620184	HEEpiC	esophagus:	n/a
4	chr5:94620042-94620092	Hepatocyte	liver:	n/a
5	chr5:94619460-94619510	K562	blood:	n/a
6	chr5:94621030-94621080	NHDF-neo	bronchial:	n/a
7	chr5:94620959-94621009	NHBE	bronchial:	n/a
8	chr5:94619460-94619510	PANC-1	pancreas:	n/a
9	chr5:94620959-94621009	HUVEC	blood vessel:	n/a
10	chr5:94619419-94619469	CMK	blood:	n/a
11	chr5:94620042-94620092	SK-N-SH_RA	brain:	n/a
12	chr5:94621517-94621567	SAEC	small airway:	n/a
13	chr5:94621517-94621567	HIPEpiC	eye:	n/a
14	chr5:94620959-94621009	ovcar-3	ovarian:	n/a
15	chr5:94621055-94621105	LNCaP	prostate:	n/a
16	chr5:94620134-94620184	HCF	heart:	n/a
17	chr5:94620929-94620979	NB4	blood:	n/a
18	chr5:94620929-94620979	T-47D	breast:	n/a
19	chr5:94621055-94621105	A549	lung:	n/a
20	chr5:94620042-94620092	NB4	blood:	n/a
21	chr5:94621517-94621567	GM12891	blood:	n/a
22	chr5:94619460-94619510	GM19239	blood:	n/a
23	chr5:94620959-94621009	SK-N-SH	brain:	n/a
24	chr5:94621517-94621567	HMEC	breast:	n/a
25	chr5:94620929-94620979	GM19239	blood:	n/a
26	chr5:94620134-94620184	BE2_C	brain:	n/a
27	chr5:94620959-94621009	GM12892	blood:	n/a
28	chr5:94620134-94620184	HIPEpiC	eye:	n/a
29	chr5:94620134-94620184	HAEpiC	amniotic membrane:	n/a
30	chr5:94621055-94621105	HIPEpiC	eye:	n/a
31	chr5:94620134-94620184	HPAEpiC	pulmonary alveolar:	n/a
32	chr5:94621517-94621567	NHBE	bronchial:	n/a
33	chr5:94620042-94620092	NHBE	bronchial:	n/a
34	chr5:94619419-94619469	NB4	blood:	n/a
35	chr5:94620134-94620184	GM06990	blood:	n/a
36	chr5:94621030-94621080	SKMC	muscle:	n/a
37	chr5:94620134-94620184	PrEC	prostate:	n/a
38	chr5:94621055-94621105	HRE	kidney:	n/a
39	chr5:94619460-94619510	HAEpiC	amniotic membrane:	n/a
40	chr5:94619419-94619469	ovcar-3	ovarian:	n/a
41	chr5:94621055-94621105	MCF10A-Er-Src	breast:	n/a
42	chr5:94620929-94620979	U87	brain:	n/a
43	chr5:94621030-94621080	NH-A	brain:	n/a
44	chr5:94620042-94620092	HIPEpiC	eye:	n/a
45	chr5:94620042-94620092	PANC-1	pancreas:	n/a
46	chr5:94620929-94620979	BE2_C	brain:	n/a
47	chr5:94620042-94620092	Caco-2	colon:	n/a
48	chr5:94620042-94620092	HepG2	liver:	n/a
49	chr5:94621030-94621080	HCT-116	colon:	n/a
50	chr5:94620959-94621009	HCF	heart:	n/a

No data

Variant related genes	Relation type
MCTP1	TF binding region
MCTP1	CpG island

Extended variants
information (count: 95 )
Associated
traits (count: 78 )

Variant overlapped rSNPs/rCNVs (count:95 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs143125847	chr5:94619024-94619025	Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs112580443	chr5:94619047-94619048	Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs190066969	chr5:94619057-94619058	Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs150392284	chr5:94619106-94619107	Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs563706598	chr5:94619113-94619114	Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs532893238	chr5:94619174-94619175	Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs543009119	chr5:94619221-94619222	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs33809	chr5:94619232-94619233	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
9	rs78037044	chr5:94619235-94619236	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs79386478	chr5:94619236-94619237	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs76341354	chr5:94619238-94619239	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs75895554	chr5:94619240-94619241	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs368775118	chr5:94619265-94619266	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs182633845	chr5:94619275-94619276	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs138149778	chr5:94619283-94619284	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs548562665	chr5:94619419-94619420	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs568557843	chr5:94619449-94619450	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs537121813	chr5:94619465-94619466	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs557148052	chr5:94619500-94619501	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs576954100	chr5:94619532-94619533	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs5869672	chr5:94619545-94619546	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs397998773	chr5:94619547-94619548	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs377659390	chr5:94619573-94619574	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs200304641	chr5:94619585-94619586	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs572759119	chr5:94619602-94619603	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
26	rs537246814	chr5:94619746-94619747	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs372798151	chr5:94619753-94619754	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs541438977	chr5:94619776-94619777	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs201538284	chr5:94619786-94619787	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs370172247	chr5:94619823-94619824	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs373085719	chr5:94619838-94619839	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs200472086	chr5:94619886-94619887	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs561495669	chr5:94619894-94619895	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs575323070	chr5:94619901-94619902	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs79130718	chr5:94619905-94619906	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs563951130	chr5:94619907-94619908	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs199763347	chr5:94619926-94619927	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs546374504	chr5:94619943-94619944	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs374213028	chr5:94619958-94619959	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs368282659	chr5:94619969-94619970	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs201358642	chr5:94619995-94619996	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs371315029	chr5:94620042-94620043	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
43	rs76230294	chr5:94620043-94620044	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
44	rs528761511	chr5:94620067-94620068	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
45	rs373959393	chr5:94620070-94620071	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
46	rs368172405	chr5:94620099-94620100	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs199518217	chr5:94620102-94620103	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs376598648	chr5:94620118-94620119	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs368437699	chr5:94620119-94620120	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs372433650	chr5:94620177-94620178	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:78)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
Non-small cell lung cancer	21829676	CNVD
adenomatous polyposis	22470819	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Lung cancer	18438408	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Merkel cell carcinoma	19020549	CNVD
Squamous cell cancer	20885788	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute myeloid leukemia	21251322	CNVD
lymphocytic leukemia	21291569	CNVD
Testicular cancer	18059402	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	16573809	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Mental retardation	19471318	CNVD
Renal cell carcinoma	18194544	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Cancer	20164920	CNVD
Myelodysplastic syndrome	21251322	CNVD
abnormal development	18461090	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Colorectal cancer	16774939	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:451 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:94618400-94620000	Enhancers	Fetal Brain Male	brain
2	chr5:94618400-94621200	Active TSS	Brain Inferior Temporal Lobe	brain
3	chr5:94618600-94621600	Active TSS	Brain Angular Gyrus	brain
4	chr5:94618800-94619200	Flanking Active TSS	H1 Cell Line	embryonic stem cell
5	chr5:94618800-94619200	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
6	chr5:94618800-94619200	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
7	chr5:94618800-94619200	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
8	chr5:94618800-94619200	Bivalent Enhancer	Brain Germinal Matrix	brain
9	chr5:94618800-94619400	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
10	chr5:94618800-94619600	Active TSS	Right Ventricle	heart
11	chr5:94618800-94620600	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
12	chr5:94618800-94620600	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
13	chr5:94618800-94620800	Active TSS	H9 Cell Line	embryonic stem cell
14	chr5:94618800-94620800	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
15	chr5:94618800-94620800	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum
16	chr5:94619000-94619200	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
17	chr5:94619000-94619200	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
18	chr5:94619000-94619200	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
19	chr5:94619000-94619200	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
20	chr5:94619000-94619200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
21	chr5:94619000-94619200	Flanking Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
22	chr5:94619000-94619200	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
23	chr5:94619000-94619200	Flanking Bivalent TSS/Enh	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
24	chr5:94619000-94619200	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
25	chr5:94619000-94619200	Bivalent Enhancer	Primary B cells from cord blood	blood
26	chr5:94619000-94619200	Bivalent/Poised TSS	Primary T cells from cord blood	blood
27	chr5:94619000-94619200	Bivalent Enhancer	Primary hematopoietic stem cells	blood
28	chr5:94619000-94619200	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
29	chr5:94619000-94619200	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Female	--
30	chr5:94619000-94619200	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
31	chr5:94619000-94619200	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
32	chr5:94619000-94619200	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
33	chr5:94619000-94619200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
34	chr5:94619000-94619200	Bivalent Enhancer	Adipose Nuclei	Adipose
35	chr5:94619000-94619200	Flanking Active TSS	Brain Anterior Caudate	brain
36	chr5:94619000-94619200	Flanking Bivalent TSS/Enh	Brain Substantia Nigra	brain
37	chr5:94619000-94619200	Bivalent Enhancer	Colon Smooth Muscle	Colon
38	chr5:94619000-94619200	Bivalent/Poised TSS	Duodenum Mucosa	Duodenum
39	chr5:94619000-94619200	Flanking Bivalent TSS/Enh	Fetal Brain Female	brain
40	chr5:94619000-94619200	Bivalent Enhancer	Fetal Intestine Large	intestine
41	chr5:94619000-94619200	Flanking Bivalent TSS/Enh	Fetal Kidney	kidney
42	chr5:94619000-94619200	Bivalent Enhancer	Fetal Lung	lung
43	chr5:94619000-94619200	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
44	chr5:94619000-94619200	Bivalent Enhancer	Fetal Muscle Leg	muscle
45	chr5:94619000-94619200	Bivalent Enhancer	Placenta	Placenta
46	chr5:94619000-94619200	Flanking Bivalent TSS/Enh	Psoas Muscle	Psoas
47	chr5:94619000-94619200	Bivalent/Poised TSS	Rectal Mucosa Donor 31	rectum
48	chr5:94619000-94619200	Bivalent/Poised TSS	Skeletal Muscle Male	skeletal muscle
49	chr5:94619000-94619200	Bivalent/Poised TSS	Skeletal Muscle Female	skeletal muscle
50	chr5:94619000-94619200	Bivalent Enhancer	Thymus	Thymus

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links